Pictet Asset Management
BMY icon

Pictet Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Pictet Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.9M Sell
1,432,429
-73,242
-5% -$4.27M 0.09% 231
2025
Q4 		$81.2M Buy
1,505,671
+7,926
+0.5% +$381K 0.08% 246
2025
Q3 		$67.5M Buy
1,497,745
+93,301
+7% +$4.36M 0.07% 268
2025
Q2 		$65M Buy
1,404,444
+8,354
+0.6% +$410K 0.07% 272
2025
Q1 		$85.1M Buy
1,396,090
+100,200
+8% +$5.84M 0.09% 223
2024
Q4 		$73.3M Buy
1,295,890
+161,739
+14% +$9.04M 0.08% 246
2024
Q3 		$58.7M Buy
1,134,151
+41,799
+4% +$1.96M 0.06% 268
2024
Q2 		$45.4M Buy
1,092,352
+42,253
+4% +$1.89M 0.05% 301
2024
Q1 		$56.9M Sell
1,050,099
-54,303
-5% -$2.77M 0.06% 284
2023
Q4 		$56.7M Buy
1,104,402
+15,320
+1% +$804K 0.06% 280
2023
Q3 		$63.2M Buy
+1,089,082
New +$66.7M 0.08% 254

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management's BMY Position: Q1 2026 in Review

Pictet Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 4.9% in Q1 2026, selling an estimated $4.27M and leaving 1,432,429 shares worth $86.9M. The position accounts for 0.09% of the portfolio, ranked #231.

Pictet Asset Management first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Pictet Asset Management held 1,432,429 shares of Bristol-Myers Squibb worth $86.9M as of Q1 2026.
  • Pictet Asset Management sold 73,242 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.27M.
  • Bristol-Myers Squibb made up 0.09% of Pictet Asset Management's portfolio in Q1 2026, its #231 holding.
  • Pictet Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.